GRI Bio (GRI) News Today → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free GRI Stock Alerts 0.43 0.00 (-0.05%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGRI Bio to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment Webinarglobenewswire.com - April 25 at 9:15 AMGRI Bio (NASDAQ:GRI) Stock Price Down 2.8%americanbankingnews.com - April 24 at 3:00 AMGRI Bio, Inc.: GRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patentfinanznachrichten.de - April 18 at 7:33 PMGRI Bio Expands Intellectual Property Protection for Proprietary Natural Killer T (NKT) Cell Modulators with Issuance of Korea Patentglobenewswire.com - April 16 at 8:35 AMGRI Bio Announces Abstract Accepted for Poster Presentation at the 2024 American Thoracic Society International Conferenceglobenewswire.com - April 8 at 8:35 AMGRI Bio Reports Full Year 2023 Financial Results and Provides Corporate Updateglobenewswire.com - April 1 at 7:35 AMGRI Bio to Present at the MedInvest Biotech & Pharma Investor Conferenceglobenewswire.com - March 28 at 9:00 AMGRI Bio, Inc.: GRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulatorsfinanznachrichten.de - March 14 at 1:50 PMGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulatorsfinance.yahoo.com - March 14 at 8:50 AMGRI Bio Announces Notice of Allowance for Canadian Patent Covering Proprietary Natural Killer T (NKT) Cell Modulatorsglobenewswire.com - March 14 at 8:45 AMGRI Bio, Inc.: GRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdomfinanznachrichten.de - March 4 at 12:43 PMGRI Bio Receives MHRA Authorization to Conduct Phase 2a Biomarker Study Evaluating GRI-0621 in the United Kingdomglobenewswire.com - March 4 at 8:30 AMTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)benzinga.com - February 23 at 7:50 AMGRI Bio Launches Major Securities Public Offeringmsn.com - February 3 at 2:55 PMGRI Bio prices 5M shares at $1.10 in public offeringmsn.com - February 2 at 12:29 PMGRI Bio Shares Drop After Stock Offering Prices Below Thursday's Closemarketwatch.com - February 2 at 12:29 PMGRI Bio Announces Pricing Of $5.5 Mln Public Offering, Stock Downmarkets.businessinsider.com - February 2 at 12:29 PMWhy Is GRI Bio (GRI) Stock Down 21% Today?investorplace.com - February 2 at 11:07 AMmarketbeat.com - February 1 at 10:36 AMmarketbeat.com - February 1 at 10:32 AMmarketbeat.com - February 1 at 10:27 AMmarketbeat.com - February 1 at 10:14 AMmarketbeat.com - February 1 at 10:08 AMmarketbeat.com - January 30 at 6:08 AMGRI Bio, Inc.: GRI Bio Announces Reverse Stock Splitfinanznachrichten.de - January 26 at 7:25 PMGRI Bio's board OKs 1-for-7 reverse stock splitmsn.com - January 26 at 7:25 PMGRI Bio Announces Reverse Stock Splitfinance.yahoo.com - January 26 at 7:25 PMGRI Bio, Inc. (GRI) Stock Historical Prices & Data - Yahoo Financefinance.yahoo.com - January 9 at 1:17 PMWeed dispensary plan scrapped at old Rainforest Cafe in River Northchicago.suntimes.com - January 3 at 8:18 PMGRI Bio files to sell common stock, warrantsmsn.com - December 21 at 5:45 PMGRI Bio Says FDA Clears IND For GRI-0621 For Treatment Of IPF; Stock Up 19%markets.businessinsider.com - November 27 at 10:18 PMGRI Bio stock slides 9% amid FDA clearance for testing of IPF drugmsn.com - November 27 at 5:18 PMGRI Bio Inc GRImorningstar.com - November 24 at 11:15 PMGRI Bio, Inc.: GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 15 at 3:10 PMGRI Bio reports Q3 resultsmsn.com - November 15 at 3:10 PMLawsuit alleges plan to open a marijuana store in former Rainforest Cafe is illegalmsn.com - November 6 at 8:26 PMPot shop company files suit to blunt planned dispensary at former Rainforest Cafe, limit proximity of minority-owned storeschicago.suntimes.com - October 31 at 5:31 PMGRI Bio Partners With NIHR Respiratory TRC To Advance NKT Regulation Technology - Quick Factsmarkets.businessinsider.com - October 17 at 3:08 PMGRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conferencefinance.yahoo.com - October 11 at 9:44 AMGRI Bio, Inc.: September Is Pulmonary Fibrosis Awareness Month: Here's What One Company Is Doing To Develop A Treatment For This Deadly Diseasefinanznachrichten.de - September 29 at 10:28 AMThinking about buying stock in SeqLL, GRI Bio, Earlyworks Co, TradeUP Acquisition, or Safety Shot?benzinga.com - September 18 at 3:55 PMDisease With Market Estimated At $3.9 Billion Lacks Cure – Will This Company Be The First To Find One?benzinga.com - September 15 at 4:11 PMElon Musk blocked Ukrainian attack on Russia's Black Sea fleet, says new biographymsn.com - September 8 at 3:29 PMIPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis - Could GRI-0621 Be The Solution?finance.yahoo.com - September 1 at 11:12 AMGRI Bio Engages B2i Digital to Deploy Cutting-Edge Engagement Campaignfinance.yahoo.com - August 29 at 12:54 PMGRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupusfinance.yahoo.com - August 25 at 1:46 PMThinking about buying stock in MicroCloud Hologram, AgileThought, GRI Bio, Profire Energy, or Foot Locker?benzinga.com - August 24 at 3:40 PMGRI Bio Shares Slide to 52-Week Low Amid Sale of Adair Asset >GRImarketwatch.com - August 23 at 6:45 PMGRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIRfinance.yahoo.com - August 23 at 6:45 PMGRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 4:24 PM Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow. Click here for your free guide GRI Media Mentions By Week GRI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRI News Sentiment▼0.330.33▲Average Medical News Sentiment GRI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRI Articles This Week▼31▲GRI Articles Average Week Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: HSTO News SBFM News ATNF News NLSP News NBSE News PBLA News CMRA News INM News PRFX News GLMD News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GRI) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
